{
  "authors": [
    {
      "author": "Ivana Trajkovska"
    },
    {
      "author": "Borce Georgievski"
    },
    {
      "author": "Lidija Cevreska"
    },
    {
      "author": "Andrijana Gacovski"
    },
    {
      "author": "Taner Hasan"
    },
    {
      "author": "Natasha Nedeska-Minova"
    }
  ],
  "doi": "10.3889/oamjms.2017.038",
  "publication_date": "2017-07-13",
  "id": "EN113969",
  "url": "https://pubmed.ncbi.nlm.nih.gov/28698754",
  "source": "Open access Macedonian journal of medical sciences",
  "source_url": "",
  "licence": "CC BY-NC",
  "language": "en",
  "type": "pubmed",
  "description": "",
  "text": "Forty-nine years old patient with AML treated with allogeneic HSCT from HLA-identical (sister) donor. Ascertained and display of early (acute Graft versus host disease (GvHD) and late complications (chronic GVHD, infections, cataract, secondary malignancy with MS deposits) are made, that emerged after the patient transplantation."
}